Product Information
KETOROLAC 0.5% OPHTH SOLUTION is a generic product labeled by Apotex Corp., priced at $1.3384 per ML under NDC 60505100302. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 5, 2009. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Apotex Corp.NDC
60505100302
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA076109FDA Approved
11/5/2009
TE Code
AT
On Market Since
12/7/2009
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 0.5% OPHTH SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3384 per ML |
|---|---|
| All-time high | $2.5920 (May 13, 2020) |
| All-time low | $0.9685 (Jul 19, 2023) |
| 52-week high | $1.4168 |
| 52-week low | $1.1713 |
| Median price | $1.3870 |
| Average price | $1.4720 |
| Largest weekly change | +57.1% (Jan 22, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ketorolac tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 0.5% OPHTH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 0.5% OPHTH SOLUTION, manufactured by Apotex Corp., is $1.3384 per ML (NDC 60505100302), effective Sep 30, 2026.
How has the price of KETOROLAC 0.5% OPHTH SOLUTION changed over time?
Over the history we have for it, the NADAC for KETOROLAC 0.5% OPHTH SOLUTION has declined 13.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOROLAC 0.5% OPHTH SOLUTION?
Since Nov 28, 2013, the NADAC for KETOROLAC 0.5% OPHTH SOLUTION has ranged from a low of $0.9685 (Jul 19, 2023) to a high of $2.5920 (May 13, 2020), with a median of $1.3870 per ML.
Are there cheaper alternatives to KETOROLAC 0.5% OPHTH SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KETOROLAC 0.5% OPHTH SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 0.5% OPHTH SOLUTION?
KETOROLAC 0.5% OPHTH SOLUTION (NDC 60505100302) is labeled by Apotex Corp., and CMS classifies it as a generic product.